Benin vs Marshall Islands: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Benin
64.0%
in 2025
Marshall Islands
62.0%
in 2025
Benin rank
139th
Marshall Islands rank
142nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Benin
- Marshall Islands
How they compare
Benin currently reports 64.0% against 62.0% in Marshall Islands, a difference of 2.0%.
The two have swapped places 5 times across 18 shared years of data; in 2008 it was Marshall Islands ahead.
Benin ranks 139th and Marshall Islands ranks 142nd of 192 countries.
Across the 3 decades both report, Benin averaged higher in 2 and Marshall Islands in 1.
Head to head by decade
| Decade | Benin | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 24.5% | 24.5% | Marshall Islands |
| 2010s | 60.2% | 51.4% | 8.8% | Benin |
| 2020s | 68.3% | 52.3% | 16.0% | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Benin or Marshall Islands?
- Benin, at 64.0% against 62.0% in Marshall Islands as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Benin and Marshall Islands?
- 2.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Marshall Islands?
- 18 years are reported by both, from 2008 to 2025.
- How do Benin and Marshall Islands rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Benin ranks 139th and Marshall Islands ranks 142nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.